CryoCor - Developing Cryogenic Technology to Treat Cardiac Rhythm Disorders

Business Opportunity

Problem – Solution

Procedure

Intellectual Property

Home > Corporate Profile

CRYOCOR PROFILE

CryoCor, Inc. is a medical technology company headquartered in San Diego, California developing products that use cryogenic technology to treat cardiac rhythm disorders called arrhythmias. Cardiac cryoablation is a non-surgical, minimally-invasive procedure in which a cardiologist inserts a catheter into a blood vessel in the leg of an afflicted individual and advances it into the heart. Once it reaches the targeted cardiac tissue, the catheter tip temperature is lowered to approximately -90°C — thereby blocking the conduction of the abnormal signals causing the heart to beat inappropriately and restoring its function to normal.

The CryoCor™ Cardiac Cryoablation System consists of a cryoablation catheter that is connected to an articulating arm mounted on the company's refrigeration console. To facilitate catheter placement, the System can be used in conjunction with CryoCor introducer sheaths.

The Cryoabalation System has been approved in Europe for the treatment of atrial fibrillation and atrial flutter, the two most common and difficult to treat arrhythmias since 2002. In the United States, CryoCor has completed enrollement in a pivotal trial to evaluate the safety and efficacy of the Cryoablation System for the treatment of the atrial fibrillation and the Cryablation System has been approved in the United States for the treatment of right atrial flutter.

[ back to top ]